BLPH   $0.105  -73.55% Market Closed

Bellerophon Therapeutics Inc
Total Cash 4.38M
totalCashPerShare 0.358
EBITDA -11.04M
Total Debt 0.00
quickRatio 3.489
currentRatio 3.964
Total Revenue 5.64M
debtToEquity
Revenue/Share 0.508
ROA -0.78474
ROE -1.6595799
grossProfits
freeCashflow -9.70M
operatingCashflow -12.34M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins -1.95656
operatingMargins -1.9576199
profitMargins -1.6406
enterpriseValue -3.69M
forwardPE
floatShares 10.20M
sharesOutstanding 12.23M
sharesShort 90.45K
sharesShortPriorMonth 123.63K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.15%
heldPercentInstitutions 0.10%
Short Ratio help_outline 1.26%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 0.304
Price To Book help_outline 0.19
earningsQuarterlyGrowth
netIncomeToCommon -9.25M
trailingEps -0.89%
forwardEps -1.82%
enterpriseToEbitda 0.33
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2023
institutionsCount 5
lastUpdated April 1, 2024, 12:04 p.m.